Explosive Markups on IV Saline Bags Reveal Hidden Healthcare Pricing Practices

Explosive Markups on IV Saline Bags Reveal Hidden Healthcare Pricing Practices The passage highlights extreme price markups on a basic medical supply and mentions major pharmaceutical manufacturers (Baxter, Hospira) and the opaque billing system, suggesting potential overbilling and fraud. However, it lacks specific transactions, dates, or direct links to high‑level officials, limiting immediate investigative steps. Key insights: IV saline bags priced at $0.44–$1 at manufacture but billed up to 1,000 times the cost.; Markups observed in a 2012 food‑poisoning outbreak affecting over 100 patients.; Manufacturers (Baxter, Hospira) claim pricing data is private despite federal reporting requirements.